Thirteen individuals, including two women, from the Banaras Hindu University (BHU), were sent to jail for organising an event that critiqued and allegedly tried to burn a copy of Manusmriti on the university campus. On December 25, the students conducted the event at the arts faculty intersection on the BHU campus to commemorate Dr BR Ambedkar’s historic burning of the Manusmriti on the same date in 1927. However, they were promptly stopped by the university security personnel leading to an altercation and eventual police detention. According to the police, the BHU security guards in their complaint alleged that the students attacked them, vandalised properties and obstructed official duties. On the other hand, eyewitness accounts state that it was the security guards who misbehaved with the students, dragged and manhandled them; injuring many. The students were later detained in the university’s proctorial board office, Maktoob Media reported. Police imposed serious charges, including non-bailable section 132 (assault on a government servant) , 121(2) (causing grievous hurt to a government servant) , 196(1)(b) (disturbing public harmony) , 299 (insulting religion) , 110 (attempt to culpable homicide) , 191(1) (rioting) , and 115(2) (causing intentional hurt) . Apart from BHU students, the arrested also included alumni and activists of a left-wing student organisation Bhagat Singh Morcha (BSM). On December 26, they were produced before the court and sent to 14 days of judicial custody. A post shared by Students for People’s Democracy (SfPD) (@sfpd.bengaluru) A post shared by Campaign Against State Repression (@kis_kis_ko_qaid_karoge)
Eli Manning and Antonio Gates are among the finalists for the Pro Football Hall of Fame Two-time Super Bowl MVP Eli Manning, former Defensive Players of the Year Luke Kuechly and Terrell Suggs, and prolific tight end Antonio Gates are among the finalists for the 2025 Pro Football Hall of Fame class. The Hall on Saturday announced the names of the 15 modern-era finalists who advanced from a group of 25 to the final stage of voting. The selection committee will vote next month to pick the class of between three and five modern-era players that will be announced the week of the Super Bowl. Georgia quarterback Carson Beck announces plan to enter NFL draft after season-ending elbow injury Georgia quarterback Carson Beck has announced his plans to enter the NFL draft, five days after having season-ending elbow surgery. The fifth-year senior made his NFL plans official on social media. Beck suffered a right elbow injury in the first half of the Bulldogs’ 22-19 overtime win over Texas in the Southeastern Conference championship game on Dec. 7. Beck had surgery on Monday to repair his ulnar collateral ligament in the elbow. He is expected to begin throwing next spring. Backup Gunner Stockton will make his first start in the Sugar Bowl against Notre Dame on Wednesday. Victor Wembanyama plays 1-on-1 chess with fans in New York Victor Wembanyama went to a park in New York City and played 1-on-1 with fans on Saturday. He even lost a couple of games. Not in basketball, though. Wemby was playing chess. Before the San Antonio Spurs left New York for a flight to Minnesota, Wembanyama put out the call on social media: “Who wants to meet me at the SW corner of Washington Square park to play chess? Im there,” Wembanyama wrote. It was 9:36 a.m. And people began showing up almost immediately. Panthers place 1,000-yard rusher Chuba Hubbard on IR for final 2 games with strained calf CHARLOTTE, N.C. (AP) — The Carolina Panthers have shut down leading rusher Chuba Hubbard for the final two games of the season because of a strained calf. He was placed on injured reserve Saturday. Hubbard was limited in practice Friday with a knee injury and was listed as questionable to play Sunday against the Tampa Bay Buccaneers. After practice, Hubbard complained of pain and had an MRI, which revealed a grade two calf strain, according to the team. Hubbard ran for 1,195 yards and 10 touchdowns this season. He becomes the third Panthers running back to be placed on injured reserve this season, joining Miles Sanders and rookie Jonathan Brooks. Patriots QB Drake Maye returns to game after evaluation for head injury vs. Chargers FOXBOROUGH, Mass. (AP) — Patriots rookie quarterback Drake Maye has returned to the game after being evaluated for a head injury following a blow to the helmet in the first quarter of New England’s matchup with the Los Angeles Chargers. Maye was scrambling near the sideline on third down of the Patriots’ first possession of the game when he was hit by Chargers cornerback Cam Hart. Maye stayed down on the turf for several seconds before eventually getting up and jogging off the field on his own power. He briefly sat on the bench before going to the medical tent and then the locker room. He was replaced by backup Jacoby Brissett in the next series. But Maye returned at the 10:15 mark of the second quarter. Corbin Burnes and Arizona Diamondbacks agree to $210 million, 6-year deal, AP source says PHOENIX (AP) — Corbin Burnes and the Arizona Diamondbacks have agreed to a $210 million, six-year contract, a person familiar with the negotiations told The Associated Press. The person spoke to the AP on condition of anonymity because the deal was pending a successful physical. The 30-year-old Burnes was perhaps the top free agent pitcher on the market after going 15-9 with a 2.92 ERA for Baltimore last season. The Orioles acquired the right-hander in a February trade after he spent his first six major league seasons with the Milwaukee Brewers. NBA coaches react with dismay over firing of 2-time coach of the year Mike Brown ORLANDO, Fla. (AP) — Not even two years ago, Rick Carlisle publicly lauded Mike Brown for the job he did on the way to winning the NBA’s coach of the year award. And on Friday, Carlisle was among the coaches reacting with dismay that Brown was fired. The Sacramento Kings dismissed Brown on Friday, with the team off to a 13-18 start this season and mired toward the bottom of the Western Conference — despite back-to-back winning seasons, something that franchise hadn’t managed in nearly two decades. Injured Philadelphia Eagles quarterback Jalen Hurts won't play Sunday against Dallas PHILADELPHIA (AP) — Injured Philadelphia Eagles quarterback Jalen Hurts won't play Sunday against Dallas. Hurts is still in the NFL concussion protocol. The Eagles will turn to backup Kenny Pickett on Sunday because Hurts is dealing with the lingering effects of a concussion suffered against Washington. Hurts was injured early at Washington after his head slammed against the ground on one run and he was hit in the helmet by Commanders linebacker Frankie Luvu at the end of another. Hurts isn’t healthy enough to play just yet. McCord throws for 453 yards, 5 TDs in No. 22 Syracuse's 52-35 Holiday Bowl win over Washington State SAN DIEGO (AP) — Kyle McCord threw for 453 yards and five touchdowns to break Deshaun Watson’s Atlantic Coast Conference season passing record and lead No. 22 Syracuse to a 52-35 victory over depleted-yet-scrappy Washington State in the Holiday Bowl on Friday night. LeQuint Allen rushed for 120 yards and two touchdowns for his second straight 1,000-yard season for the Orange (10-3), who had their first 10-win season since 2018. Fran Brown joined Paul Pasqualoni (1991) as the only Orange coaches since World War II to win 10 game in their first season. The Cougars (8-5) lost their fourth straight game but were spirited despite losing coach Jake Dickert to Wake Forest, quarterback John Mateer to Oklahoma, both coordinators and the quarterbacks and running backs coach. Southern California overcomes 17-point deficit to beat Texas A&M 35-31 in Las Vegas Bowl LAS VEGAS (AP) — Jayden Maiava threw a 7-yard touchdown pass to tight end Kyle Ford with eight seconds left to give Southern California a 35-31 victory over Texas A&M in the Las Vegas Bowl on Friday night. A graduate of Liberty High School in nearby Henderson and a transfer from UNLV, Maiava helped the Trojans (7-6) overcome a 17-point deficit. After Texas A&M quarterback Marcel Reed raced 19 yards for a touchdown with 1:49 remaining to regain the lead, Maiava drove Southern California 75 yards in 10 plays for the winning score.The Aggies (8-5) opened the third quarter by scoring 17 straight points to take a 24-7 lead.
Furthermore, the strong performance of Mao Geping on its first day of trading underscores the resilience and competitiveness of Chinese beauty brands in the global market. With a growing emphasis on innovation, quality, and sustainability, Chinese beauty companies are increasingly gaining recognition and market share on an international level, challenging the dominance of established Western beauty brands.
Plume Partners With Digift To Expand Regulated Digital Asset OfferingsOn the women's side, Sun Yingsha has also been a standout player, consistently delivering exceptional performances on the international stage. Her skills, agility, and strategic prowess have helped her to secure the top position in the women's rankings, further solidifying China's dominance in table tennis.Games on a college basketball schedule don't contrast much more than the two NC State has this week. The Wolfpack (6-3) host Coppin State (0-10) on Tuesday in Raleigh, N.C., then hit the road to challenge No. 10 Kansas on Saturday. NC State enters its unusual week after snapping a three-game skid with an 84-74 overtime win at home Saturday against Florida State in its Atlantic Coast Conference opener. Transfers Marcus Hill and Dontrez Styles each had their season high, scoring 23 and 21 points, respectively. They scored 13 of NC State's 14 points in overtime. "Dontrez Styles was tremendous," Wolfpack coach Kevin Keatts said. "In the second half, he made play after play." Hill, who was the top scorer last year at Bowling Green (20.5 points per game), and Styles, who was the second-leading scorer last year at Georgetown (12.8 ppg), combined to hit 14 of 25 shots and pull down 11 rebounds. The win followed defeats to then-No. 13 Purdue and BYU, both by double-digit margins, in the Rady Children's Invitational and a 63-59 loss to Texas in the SEC/ACC Challenge. "The little things that impact the game are defending, making free throws and blocking out," Keatts said. "We handled that much better than we did against Texas." Coppin State arrives in Raleigh on a 23-game losing streak dating to January -- the longest current run of futility in Division I. Each of the Eagles' losses this season have come by double-digit margins, though they have been more competitive lately, falling to Baltimore rival Loyola (Md.) 68-57 and at Wagner 65-52 last week. Julius Ellerbe III has been one of Coppin's most reliable players lately, scoring a combined 20 points in the last two games. He had 16 points and 12 rebounds in a loss to George Mason last month. Teammate Peter Oduro recorded a double-double, with 16 points and 10 rebounds, in last month's loss at Saint Joseph's. "These things take time," Coppin State second-year coach Larry Stewart said. "It takes time to establish your culture. It takes time to get the right players in your system." --Field Level Media
Columbia, a perennial football loser, wins Ivy League title for first time since 1961
As the esports industry continues to grow and evolve, TES remains at the forefront, driving innovation and setting new standards for excellence in competitive gaming. With Ben's arrival and the addition of two new family members, TES is well-positioned to make waves in the gaming world and inspire a new generation of esports enthusiasts.
Revolutionary Single-Layer Film Eliminates Helmet Changes, Enhancing Driver Safety and Performance LAS VEGAS , Dec. 11, 2024 /PRNewswire/ -- Racing Optics®, the global leader in high-performance tearoff visor film technology, proudly unveils its latest innovation: the Twilight Tearoff . This groundbreaking single-layer tearoff is engineered to elevate driver visibility during late-afternoon and early-evening races, providing superior glare reduction and contrast enhancement. The Twilight Tearoff redefines race-day performance by allowing drivers to maintain focus and adapt seamlessly to changing light conditions, eliminating the need for disruptive helmet changes. This innovation represents a significant leap forward in racing vision technology, delivering immediate and measurable benefits to professional drivers and teams alike. "The Twilight Tearoff solves one of racing's most persistent challenges—ensuring optimal visibility as lighting transitions rapidly during twilight races," said Chris Colton , Chief Applications Engineer at Racing Optics . "Our dedication to driver safety and performance drives every innovation, and the Twilight Tearoff is no exception." Transforming Racing at Twilight Racing teams are already embracing the Twilight Tearoff as a game-changing solution for twilight and low-light racing conditions. One racing team manager shared their experience: "In a recent twilight race, the Twilight Tearoff gave our drivers unmatched visual clarity. Transitioning from glaring sunlight to artificial lighting without pausing to change helmets was a decisive advantage that kept us competitive." By streamlining the driver experience, the Twilight Tearoff enhances safety and helps maintain uninterrupted race momentum—a critical edge in the high-stakes world of motorsports. Exclusive Debut at PRI Show 2024 The Twilight Tearoff will make its debut at the Performance Racing Industry (PRI) Show , held December 12–14, 2024, in Indianapolis, Indiana . This highly anticipated event marks Racing Optics' 25th anniversary , celebrating a legacy of trailblazing innovations in motorsports safety and performance. Availability The Twilight Tearoff is now available for purchase at RacingOptics.com and through authorized dealers. Teams and drivers looking to gain a competitive edge are encouraged to explore this latest advancement. About Racing Optics For 25 years, Racing Optics has led the field in racing vision technology, delivering innovative solutions that enhance safety and performance. With a commitment to collaboration and innovation, the company continues to push the boundaries of motorsports protective equipment. For additional information, please visit RacingOptics.com . Logo - https://mma.prnewswire.com/media/2577485/Racing_Optics_Logo.jpgHowever, it is important to remember that Mbappe was only 18 years old at the time of his transfer to PSG. He was still a raw talent, with a long way to go in terms of his development as a player. While he has undoubtedly shown flashes of brilliance during his time at PSG, he has also struggled with injuries and inconsistency.Investors were particularly impressed by Maogeping's track record of revenue growth and profitability, with the company delivering strong financial results quarter after quarter. This consistent performance has helped build investor confidence in Maogeping's ability to sustain its growth trajectory in the long term.
Hegseth meets with moderate Sen. Collins as he lobbies for key votes in the Senate
The extent of Zhong Moyan's corruption has sent shockwaves through the school community, with many parents and teachers expressing outrage and disappointment. The principal, who was once seen as a respected and trusted leader, has now become the face of dishonesty and greed.PROVIDENCE, Rhode Island, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. ( NASDAQ : OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC ("Nasdaq”) stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the "Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission (the "SEC”). Ocean Biomedical is delayed in filing the Form 10-Q as a result of previously disclosed developments with respect to filing of its 10-K for the year ended December 31, 2023. The current notice will have no immediate effect on the listing or trading of Ocean Biomedical's common stock on Nasdaq, although there can be no assurances that further delays in the filing of the Form 10-Q will not have an impact on the listing or trading of the company's common stock. On October 16, 2024, Staff notified the Company that since it failed to timely file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, 2024 and June 30, 2024, the Company's securities were subject to delisting. The Company is now delinquent in the filing its form 10-Q for the period ended September 30, 2024. Accordingly, this matter serves as an additional basis for delisting the Company's securities from The Nasdaq Stock Market. This is formal notification that the Nasdaq Hearings Panel (the "Panel”) will consider this matter in their decision regarding the Company's continued listing on The Nasdaq Capital Market, which hearing is scheduled for December 16, 2024. The Company intends to file the delinquent Forms 10-Q and 10-K as soon as practicable. About Ocean Biomedical Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world's toughest problems, for the people who need it most. To learn more, visit www.oceanbiomedical.com . Forward-Looking Statements The information included herein and in any oral statements made on behalf of Ocean Biomedical, Inc. (the "Company”) or otherwise in connection herewith include "forward-looking statements” within the meaning of the "safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate,” "plan,” "project,” "forecast,” "intend,” "will,” "expect,” "anticipate,” "believe,” "seek,” "target,” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters, although not all forward-looking statements contain such identifying words. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics and expectations; the expected timing and success of IND filings for our initial product candidates; statements regarding the expected timing of our IND-enabling studies; the frequency and timing of filing additional INDs; expectations regarding the availability and addition of future assets to our pipeline; the advantages of any of our pipeline assets and platforms; the potential benefits of our product candidates; potential commercial opportunities; the timing of key milestones for our programs; the future financial condition, results of operations, business strategy and plans, and objectives of management for future strategy and operations; and statements about industry trends and other companies in the industry. These forward-looking statements are based on various assumptions, whether or not identified herein, and on the current expectations of the Company's management, and they are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Any discoveries announced by the Company are based solely on laboratory and animal studies. The Company has not conducted any studies that show similar efficacy or safety in humans. There can be no assurances that any treatment tested by the Company will prove safe or effective in humans, and that any clinical benefits of any such treatment is subject to clinical trials and ultimate approval of its use in patients by the FDA. Such approval, if granted, could be years away. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the control of the Company that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should carefully consider the foregoing factors and the other risks and uncertainties that are described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and other documents filed by the Company from time to time with the SEC and which are and are available at www.sec.gov . These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. We do not undertake any obligation to update any forward-looking statements made by us. These forward-looking statements should not be relied upon as representing the Company's assessments as of any date subsequent to the date of this filing. Accordingly, undue reliance should not be placed upon the forward-looking statements. Contacts: Ocean Biomedical Investor Relations [email protected] Kevin Kertscher Communications Director
